The primary health care provider prescribes cyclophosphamide to a patient with multiple myeloma. which complication should the nurse monitor the patient for that can be suspected in this patient?

Studies and research have shown cyclophosphamide to be a promising therapy for patients with multiple myeloma. However, given the intensive of the therapy, there is a strong risk of serious complications. The most prevalent of these is high-grade neutropenia, which can leave the patient extremely susceptible to infections.